LDS/Medical Tests/Nervous System/Brain Cancer Panel, NGS

Nervous System/Brain Cancer Panel, NGS

Malignant tumors of the brain and spinal cord including the meninges, pituitary gland, pineal gland, and nerves constitute the Central nervous system cancers. Mutations of over 15 genes are known to be responsible for these cancers. Most of mutations have an autosomal dominant inheritance pattern and very few are inherited in an autosomal recessive pattern. Central Nervous System cancers are diagnosed primarily on histopathological features. However, morphologically similar tumors show variable molecular markers and consequently have different prognosis and management strategies. Following genes are implicated in pathogenesis of CNS cancers: HRAS, MEN1, MLH1, PRKAR1A, PTCH1, PTEN, SMARCA4, SMARCB1, ALK, APC, ATM, DICER1, EPCAM, SMARCE1, PHOX2B, PMS2, POT1, SUFU, TP53, TSC1, TSC2, VHL MSH2, MSH6.

Panel Components

Although it depends on the laboratory and the clinical utility this panel uses targeted next-generation sequencing to evaluate for most common variants within genes: HRAS, MEN1, MLH1, PRKAR1A, PTCH1, PTEN, SMARCA4, SMARCB1, ALK, APC, ATM, DICER1, EPCAM, SMARCE1, PHOX2B, PMS2, POT1, SUFU, TP53, TSC1, TSC2, VHL MSH2, MSH6.

  • As an aid in diagnosis of CNS cancers
  • As an aid in classification of CNS cancers
  • In understanding prognosis of CNS cancers
  • Disease and therapy management
Any mutation, deletions or duplication of relevant genes in conjunction with appropriate clinical and epidemiological information might be diagnostic or consistent with the disease.

Negative for mutation analyze (No reportable variants were identified)

Next Generation Sequencing, Sanger Sequencing, Gene-targeted deletion/duplication analysis, gel electrophoresis.

Whole blood (EDTA), Formalin-Fixed, Paraffin-Embedded Tissue (FFPE).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Brain biopsy, Specific Immunohistochemistry stains (markers), Fluorescence In Situ Hybridization (FISH).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login